RAAS Inhibitors and Risk of Covid-19 REPLY

被引：0
|
作者：
Reynolds, Harmony R. [1 ]
Adhikari, Samrachana [1 ]
Iturrate, Eduardo [1 ]
机构：
[1] NYU, Grossman Sch Med, New York, NY 10003 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1993 / 1994
页数：2
相关论文
共 50 条
  • [1] RAAS Inhibitors and Risk of Covid-19
    Islam, Nazrul
    Khunti, Kamlesh
    Chowell, Gerardo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20): : 1992 - 1992
  • [2] RAAS inhibitors do not increase the risk of COVID-19
    Fernandez-Ruiz, Irene
    [J]. NATURE REVIEWS CARDIOLOGY, 2020, 17 (07) : 383 - 383
  • [3] RAAS inhibitors do not increase the risk of COVID-19
    Irene Fernández-Ruiz
    [J]. Nature Reviews Cardiology, 2020, 17 : 383 - 383
  • [4] Reply to: RAAS inhibitors in COVID-19: Not all are created equal!
    Goncalves, Jorge
    Santos, Catarina D.
    Fresco, Paula
    Fernandez-Llimos, Fernando
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (09) : 817 - 818
  • [5] RAAS inhibitors in COVID-19: They are not all the same!
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (09) : 815 - 816
  • [6] RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
    Holmes, Adam R.
    Nelson, Jacob
    Hirschl, Jacob
    Perkins, Sidney J.
    Chopra, Zoey
    Fung, Christopher
    Medlin, Richard P., Jr.
    Korley, Frederick K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3073 - 3073
  • [7] COVID-19 and RAAS inhibitors: is there a final conclusion?
    Talebi-Taher, Mahshid
    Najafi, Mohammad Hosein
    Behzad, Shima
    [J]. IRANIAN JOURNAL OF MICROBIOLOGY, 2021, 13 (06) : 728 - 736
  • [8] Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’
    Ying-Ying Zheng
    Yi-Tong Ma
    Jin-Ying Zhang
    Xiang Xie
    [J]. Nature Reviews Cardiology, 2020, 17 : 313 - 314
  • [9] Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'
    Zheng, Ying-Ying
    Ma, Yi-Tong
    Zhang, Jin-Ying
    Xie, Xiang
    [J]. NATURE REVIEWS CARDIOLOGY, 2020, 17 (05) : 313 - 314
  • [10] Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
    Goncalves, Jorge
    Santos, Catarina D.
    Fresco, Paula
    Fernandez-Llimos, Fernando
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2024, 43 (04) : 221 - 222
12345